Breast Cancer

Breast Cancer
2023-05-23T00:00:00.000+01:00
Ongoing

VIKTORIA-1

VIKTORIA-1
Breast cancer

Phase 3, open-label, randomized, clinical trial evaluating the efficacy and safety of Gedatolisib plus Fulvestrant with or without Palbociclib for the treatment of patients with locally advanced or metastatic HR+/HER2- breast cancer following progression on or after CDK4/6 and aromatase inhibitor therapy.

Phase 3, open-label, randomized, clinical trial evaluating the efficacy and safety of Gedatolisib plus Fulvestrant with or without Palbociclib for the treatment of patients with locally advanced or metastatic HR+/HER2- breast cancer following progression on or after CDK4/6 and aromatase inhibitor therapy.

Trial overview

Clinical Area

Medical Oncology

Disease / Condition

Breast

Study Phase

III

Trial Identifiers

Registration number: NCT05501886

https://clinicaltrials.gov/study/NCT05501886

GenesisCare Location(s)
St Andrew's Precinct (Oncology)
location pin icon

Level 1, 337 South Terrace, Adelaide, SA, 5000, Australia

phone icon (08) 8228 6700 email icon infooncologysa@genesiscare.com
SA
St Andrew's Precinct (Oncology)
Principal Investigator(s)
Medical Oncologist

A/Prof Nick Murray

BM MS MA DPhil FRCP(Lon) FRACP

A/Prof Nick Murray
location pin icon

St Andrew's Precinct (Oncology)

View Profile
Profile Image - A/Prof Nick  Murray

Thank you for submitting.

We will be in touch within 24 hours

An unexpected error has occurred.

You will need to complete the form again, sorry for the inconvenience.

How can we help?

If you have a medical emergency please call 000. If you have an urgent request and would like to speak to our staff, please contact one of our centres directly.

* Indicates a required field.